1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > DiaGenic ASA (NEL) - Product Pipeline Analysis, 2016 Update

Summary

DiaGenic ASA (DiaGenic) is a medical company that creates value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from the absence of dementia. DiaGenic also has IP position, unique access to biobanks and mature technology in late stage development of products for commercialization in major markets. The company’s tests are based on the observation that a focal lesion or disorder gives rise to a systemic response which can be measured in the blood. DiaGenic is headquartered in Oslo, Norway.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company DiaGenic ASA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

DiaGenic ASA (NEL) - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2


DiaGenic ASA Company Snapshot 6
DiaGenic ASA Company Overview 6
DiaGenic ASA Pipeline Products and Clinical Trials Overview 7
DiaGenic ASA - Pipeline Analysis Overview 9
Key Facts 9
DiaGenic ASA - Major Products and Services 10
DiaGenic ASA Pipeline Products by Development Stage 11
DiaGenic ASA Pipeline Products Overview 13
ADtect PLUS 13
ADtect PLUS Product Overview 13
ADtect ULTRA 14
ADtect ULTRA Product Overview 14
AMYtect 15
AMYtect Product Overview 15
MCItect - New Version 16
MCItect - New Version Product Overview 16
MCItect PLUS 17
MCItect PLUS Product Overview 17
MCItect ULTRA 18
MCItect ULTRA Product Overview 18
New ADtect 19
New ADtect Product Overview 19
PDtect 20
PDtect Product Overview 20
DiaGenic ASA - Key Competitors 21
DiaGenic ASA - Key Employees 22
DiaGenic ASA - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
DiaGenic ASA, Recent Developments 24
Aug 21, 2014: DiaGenic Announces Q2 2014 Financial Report 24
Mar 20, 2014: DiaGenic Appoints New CEO 24
Feb 20, 2014: DiaGenic: Report from Fourth Quarter 2013 24
Jan 31, 2014: DiaGenic: New CEO and New Company Address 25
Jan 23, 2014: DiaGenic reports AMYtect study results 25
Nov 22, 2013: Extraordinary General Meeting held in DiaGenic 26
Nov 22, 2013: Extraordinary general meeting held in DiaGenic ASA 26
Nov 13, 2013: DiaGenic ASA: Report from third quarter 2013 26
Nov 11, 2013: DiaGenic To Present results for third quarter 2013 27
Oct 29, 2013: DiaGenic provides update on AMYtect study 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
DiaGenic ASA Pipeline Products and Clinical Trials Overview 7
DiaGenic ASA Pipeline Products by Equipment Type 7
DiaGenic ASA Pipeline Products by Indication 8
DiaGenic ASA, Key Facts 9
DiaGenic ASA, Major Products and Services 10
DiaGenic ASA Number of Pipeline Products by Development Stage 11
DiaGenic ASA Pipeline Products Summary by Development Stage 12
ADtect PLUS - Product Status 13
ADtect PLUS - Product Description 13
ADtect ULTRA - Product Status 14
ADtect ULTRA - Product Description 14
AMYtect - Product Status 15
AMYtect - Product Description 15
MCItect - New Version - Product Status 16
MCItect - New Version - Product Description 16
MCItect PLUS - Product Status 17
MCItect PLUS - Product Description 17
MCItect ULTRA - Product Status 18
MCItect ULTRA - Product Description 18
New ADtect - Product Status 19
New ADtect - Product Description 19
PDtect - Product Status 20
PDtect - Product Description 20
DiaGenic ASA, Key Employees 22

List of Figures
DiaGenic ASA Pipeline Products by Equipment Type 8
DiaGenic ASA Pipeline Products by Development Stage 11

Companies Mentioned
Nattopharma ASA
Midsona AB
Biotec Pharmacon ASA

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Gene Expression Industry, 2016 Market Research Report

Global and Chinese Gene Expression Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Gene Expression Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Gene Expression industry with a focus on ...

Global Microarray Market 2016-2020

Global Microarray Market 2016-2020

  • $ 2500
  • Industry report
  • November 2016
  • by Infiniti Research Limited

About Microarray A microarray is an advanced tool used in molecular biology. It allows end-users to conduct high-throughput and highly parallel analyses of more than thousand points of interest that include ...

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2016

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.